UnitedHealth Group (NYSE:UNH) Stock Keeps Hold Rating at TD Cowen

UnitedHealth Group (NYSE:UNH)‘s stock had its “hold” rating reiterated by equities research analysts at TD Cowen in a research note issued on Thursday, Benzinga reports. They presently have a $402.00 price target on the healthcare conglomerate’s stock. TD Cowen’s price objective would indicate a potential downside of 1.34% from the company’s previous close.

UNH has been the topic of a number of other research reports. Bank of America reissued a “buy” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research note on Monday, July 20th. Royal Bank Of Canada boosted their price objective on UnitedHealth Group from $463.00 to $478.00 and gave the stock an “outperform” rating in a research note on Friday, July 17th. Deutsche Bank Aktiengesellschaft boosted their price objective on UnitedHealth Group from $370.00 to $467.00 and gave the stock a “hold” rating in a research note on Friday, July 17th. Cantor Fitzgerald upped their price target on UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Finally, JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Twenty research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $461.48.

UnitedHealth Group Trading Up 3.0%

NYSE UNH traded up $11.83 on Thursday, reaching $407.45. 10,137,516 shares of the company were exchanged, compared to its average volume of 7,394,461. The business’s fifty day moving average price is $387.10 and its 200 day moving average price is $383.47. The stock has a market capitalization of $365.72 billion, a P/E ratio of 23.27, a price-to-earnings-growth ratio of 1.41 and a beta of 0.60. The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. UnitedHealth Group has a fifty-two week low of $255.96 and a fifty-two week high of $461.62.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The company had revenue of $112.70 billion for the quarter, compared to analyst estimates of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Analysts forecast that UnitedHealth Group will post 20.00 earnings per share for the current year.

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently modified their holdings of the company. Synergy Financial Group LTD raised its holdings in shares of UnitedHealth Group by 3.1% in the 2nd quarter. Synergy Financial Group LTD now owns 887 shares of the healthcare conglomerate’s stock valued at $369,000 after buying an additional 27 shares during the period. LFG Wealth Partners LLC increased its holdings in UnitedHealth Group by 3.3% during the 2nd quarter. LFG Wealth Partners LLC now owns 853 shares of the healthcare conglomerate’s stock worth $355,000 after purchasing an additional 27 shares during the period. Ares Financial Consulting LLC increased its holdings in UnitedHealth Group by 7.2% during the 2nd quarter. Ares Financial Consulting LLC now owns 419 shares of the healthcare conglomerate’s stock worth $174,000 after purchasing an additional 28 shares during the period. Hudock Inc. increased its holdings in UnitedHealth Group by 1.0% during the 2nd quarter. Hudock Inc. now owns 2,844 shares of the healthcare conglomerate’s stock worth $1,182,000 after purchasing an additional 28 shares during the period. Finally, Rockland Trust Co. increased its holdings in UnitedHealth Group by 1.1% during the 2nd quarter. Rockland Trust Co. now owns 2,589 shares of the healthcare conglomerate’s stock worth $1,076,000 after purchasing an additional 29 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and raised outlook: UnitedHealth reported $112.7 billion in revenue and adjusted earnings of $4.69 per share, exceeding consensus estimates. Management raised its 2026 adjusted earnings outlook to at least $20.50 per share from a prior $19.50-$20.00 range. UnitedHealth Stock Moves Higher: What’s Going On?
• Positive Sentiment: Improving medical-cost trends: The medical care ratio improved to 88.4%, while Optum generated $66.9 billion in revenue and $3.7 billion in earnings. Investors viewed better cost management, pricing discipline and benefit changes as evidence that margins may recover across the business. UnitedHealth Group gains after Q3 beat and higher 2026 outlook
• Positive Sentiment: Potential Medicare and 2027 growth drivers: UnitedHealth’s emphasis on special-needs plans, expanded Medicare coverage, AI initiatives and expected Medicaid margin improvement after 2026 could support targeted growth. Goldman Sachs raised its price target to $506, while Piper Sandler maintained an overweight rating and a $504 target. Goldman Sachs raises UNH target price to $506 following Q3 earnings beat
• Neutral Sentiment: Analyst views are mixed: Some firms see substantial upside after the earnings beat, but TD Cowen reaffirmed a hold rating with a $402 target, below the recently traded level. Seeking Alpha commentary also cautioned that much of the improved outlook may already be reflected in the stock.
• Negative Sentiment: Growth and cost concerns remain: Revenue was roughly flat year over year, membership has declined, and commercial medical costs and Medicaid pressures continue to weigh on margins. These issues caused some investors to question whether the earnings improvement can translate into durable growth. UnitedHealth Beats on Earnings, But Investors Question Growth Path

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.